We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
-1.06%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+433.28%
AUM
$481B
AUM Growth
+$34.6B
Cap. Flow
+$38.1B
Cap. Flow %
7.92%
Top 10 Hldgs %
29.35%
Holding
15,428
New
1,884
Increased
5,796
Reduced
5,769
Closed
1,724

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$1.26B
2
MSFT icon
Microsoft
MSFT
+$633M
3
BABA icon
Alibaba
BABA
+$501M
4
ATVI
Activision Blizzard
ATVI
+$484M
5
AAPL icon
Apple
AAPL
+$456M

Sector Composition

Rank Sector Weight
1 Technology 3.03%
2 Consumer Discretionary 2.25%
3 Healthcare 2.2%
4 Financials 2.18%
5 Industrials 1.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AXU
13051
DELISTED
Alexco Resource Corp
AXU
$70K ﹤0.01%
+46,593
New +$88.9K
VISL
13052
PUT
DELISTED
Vislink Technologies, Inc. Common Stock
VISL
$70K ﹤0.01%
1,935
-870
-31% -$37.7K
YDKG
13053
Yueda Digital Holding
YDKG
$5.81M
$69K ﹤0.01%
66
-39
-37% -$39.4K
NFGC
13054
New Found Gold
NFGC
$522M
$69K ﹤0.01%
+11,316
New +$69.2K
WWR icon
13055
PUT
Westwater Resources
WWR
$52.4M
$69K ﹤0.01%
19,200
-41,200
-68% -$161K
YQ
13056
17 Education & Technology Group
YQ
$18.7M
$69K ﹤0.01%
3,813
-9,586
-72% -$285K
BEST
13057
PUT
DELISTED
BEST Inc. American Depositary Shares, each representing twenty (20) Class A Ordinary Shares
BEST
$69K ﹤0.01%
2,075
-6,260
-75% -$163K
ID
13058
DELISTED
PARTS iD, Inc.
ID
$69K ﹤0.01%
+13,273
New +$84.3K
AXLA
13059
PUT
DELISTED
Axcella Health Inc. Common Stock
AXLA
$69K ﹤0.01%
+924
New +$79.2K
HMPT
13060
DELISTED
Home Point Capital, Inc Common Stock
HMPT
$69K ﹤0.01%
+16,737
New +$77.2K
ZWRKW
13061
DELISTED
Z-Work Acquisition Corp. Warrant
ZWRKW
$69K ﹤0.01%
+107,915
New +$84.3K
KLDO
13062
PUT
DELISTED
Kaleido Biosciences, Inc. Common Stock
KLDO
$69K ﹤0.01%
12,700
-29,900
-70% -$185K
CXDC
13063
DELISTED
China XD Plastics Company Limited
CXDC
$69K ﹤0.01%
152,200
+91,524
+151% +$50.3K
TIO
13064
DELISTED
Tingo Group, Inc. Common Stock
TIO
$69K ﹤0.01%
44,551
-4,830
-10% -$8.97K
ADTX
13065
CALL
DELISTED
ADITXT INC
ADTX
0
AMPY icon
13066
PUT
Amplify Energy
AMPY
$161M
$68K ﹤0.01%
12,700
-12,100
-49% -$45.4K
ANIX icon
13067
Anixa Biosciences
ANIX
$116M
$68K ﹤0.01%
+14,258
New +$64.3K
AVTX icon
13068
Avalo Therapeutics
AVTX
$965M
$68K ﹤0.01%
11
+3
+38% +$24.3K
DHX icon
13069
DHI Group
DHX
$182M
$68K ﹤0.01%
+14,262
New +$55.9K
PMCB icon
13070
CALL
PharmaCyte Biotech
PMCB
$6.18M
$68K ﹤0.01%
+21,300
New +$74.9K
DNA.WS
13071
DELISTED
Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share
DNA.WS
$68K ﹤0.01%
+20,059
New +$71.4K
ASPU
13072
PUT
DELISTED
ASPEN GROUP, INC.
ASPU
$68K ﹤0.01%
+12,200
New +$73.7K
NDACW
13073
DELISTED
NightDragon Acquisition Corp. Warrants to purchase Class A common stock
NDACW
$68K ﹤0.01%
79,519
-21
-0% -$24
TYME
13074
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
$68K ﹤0.01%
66,403
-10,549
-14% -$11.6K
ONCS
13075
DELISTED
OncoSec Medical Incorporated
ONCS
$68K ﹤0.01%
1,464
+983
+204% +$49.8K

Similar funds

Citadel Advisors's Q3 2021 Portfolio in Review

As of Q3 2021, Citadel Advisors held 15,428 positions worth $481B, up 7.8% from $447B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Citadel Advisors deployed $38.1B of net new capital in Q3 2021, opening 1,884 new positions and adding to 5,796 existing holdings. Its largest new stake was Etsy: 948,509 shares worth $197M.

By sector, the portfolio is most concentrated in Technology at 3% of assets, down from 3% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $622M trimmed.

  • Citadel Advisors's largest Q3 2021 buy was Etsy: 948,509 shares worth $197M.
  • Citadel Advisors added most to Tesla in Q3 2021, an estimated $1.26B increase.
  • Citadel Advisors's biggest Q3 2021 reduction was Meta Platforms (Facebook), cutting an estimated $622M.
  • Citadel Advisors fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $597M.
  • Citadel Advisors's ten largest holdings make up 29% of its $481B portfolio in Q3 2021.
  • Citadel Advisors opened 1,884 new positions and closed 1,724 in Q3 2021.
  • Citadel Advisors's portfolio value rose 7.8% quarter-over-quarter to $481B.

Based on Citadel Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.